Thailand Orphan Drugs Market (2024-2030) Outlook | Size, Companies, Forecast, Growth, Value, Industry, Revenue, Share, Analysis & Trends

Market Forecast By Drugs (Revlimid, Rituxan, Opdivo, Keytruda, Imbruvica, Soliris, Other Orphan Drugs), By Drug Type (Biologics, Non-Biologics), By Therapy Class (Oncology, Blood, Endocrine, Central Nervous Systems, Cardiovascular, Respiratory) And Competitive Landscape
Product Code: ETC070124 Publication Date: Jul 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Thailand Orphan Drugs Market Synopsis

The orphan drugs market in Thailand has been steadily growing, driven by increasing awareness and advocacy for rare diseases and orphan conditions. Orphan drugs are pharmaceutical products developed to treat rare diseases that affect a small number of patients. In Thailand, the government and healthcare stakeholders have recognized the importance of addressing the unmet medical needs of patients with rare diseases, leading to favorable regulatory policies and incentives for orphan drug development. As a result, the market for orphan drugs has gained traction, offering new hope and treatment options to patients and their families.

Market Drivers

Several drivers contribute to the growth of the orphan drugs market in Thailand. Firstly, the growing prevalence of rare diseases and the recognition of their impact on patients` quality of life have spurred the demand for effective treatments. Orphan drugs, specifically tailored for these conditions, offer new therapeutic possibilities. Secondly, government support, including expedited regulatory approval processes and incentives for orphan drug development, has encouraged pharmaceutical companies to invest in research and development. Additionally, advancements in biotechnology and precision medicine have facilitated the discovery and development of targeted therapies for rare diseases.

Challenges of the Market

Despite its potential, the orphan drugs market in Thailand faces certain challenges. One significant challenge is the high cost of orphan drugs due to the limited patient population they serve. Ensuring affordability and accessibility of these drugs to patients is a concern for both healthcare providers and pharmaceutical companies. Additionally, the lack of awareness and expertise among healthcare professionals about rare diseases and their diagnosis can lead to delays in accurate diagnosis and treatment initiation. Educating healthcare providers and raising public awareness about rare diseases are essential steps to overcome this challenge.

Covid-19 Impact on the Market

The Covid-19 pandemic has had varying effects on the orphan drugs market in Thailand. While the immediate focus during the pandemic was on Covid-19 treatments and vaccines, the importance of ensuring continued access to orphan drugs for patients with rare diseases was highlighted. The pandemic also underscored the need for resilient supply chains to ensure a steady supply of essential medicines, including orphan drugs. Moreover, disruptions in healthcare services and patient care during lockdowns posed challenges to patients with rare diseases, necessitating innovative approaches, such as telemedicine, to ensure continuity of care.

Key Players of the Market

The orphan drugs market in Thailand is supported by several key players, including multinational pharmaceutical companies and biotech firms. These players are actively involved in the development and commercialization of orphan drugs for rare diseases. Local pharmaceutical companies, such as Mega Lifesciences Public Company Limited, have also been engaged in providing orphan drugs and support services to patients with rare conditions in Thailand. Additionally, international organizations and patient advocacy groups play a crucial role in raising awareness, providing resources, and advocating for better access to orphan drugs and healthcare services for patients with rare diseases in Thailand. Collaborations between these key players and healthcare institutions contribute to advancing the orphan drugs market and improving patient outcomes in the country.

Key Highlights of the Report:

  • Thailand Orphan Drugs Market Outlook
  • Market Size of Thailand Orphan Drugs Market, 2020
  • Forecast of Thailand Orphan Drugs Market, 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Revenues & Volume for the Period 2023 - 2027
  • Thailand Orphan Drugs Market Trend Evolution
  • Thailand Orphan Drugs Market Drivers and Challenges
  • Thailand Orphan Drugs Price Trends
  • Thailand Orphan Drugs Porter's Five Forces
  • Thailand Orphan Drugs Industry Life Cycle
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Drugs for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Revlimid for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Rituxan for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Opdivo for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Keytruda for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Imbruvica for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Soliris for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Other Orphan Drugs for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Drug Type for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Biologics for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Non-Biologics for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Therapy Class for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Oncology for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Blood for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Endocrine for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Central Nervous Systems for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Cardiovascular for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Orphan Drugs Market Revenues & Volume By Respiratory for the Period 2023 - 2027
  • Thailand Orphan Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Drugs
  • Market Opportunity Assessment By Drug Type
  • Market Opportunity Assessment By Therapy Class
  • Thailand Orphan Drugs Top Companies Market Share
  • Thailand Orphan Drugs Competitive Benchmarking By Technical and Operational Parameters
  • Thailand Orphan Drugs Company Profiles
  • Thailand Orphan Drugs Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Thailand Orphan Drugs Market Overview

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Orphan Drugs Market Revenues & Volume, 2020 & 2027F

3.3 Thailand Orphan Drugs Market - Industry Life Cycle

3.4 Thailand Orphan Drugs Market - Porter's Five Forces

3.5 Thailand Orphan Drugs Market Revenues & Volume Share, By Drugs, 2020 & 2027F

3.6 Thailand Orphan Drugs Market Revenues & Volume Share, By Drug Type, 2020 & 2027F

3.7 Thailand Orphan Drugs Market Revenues & Volume Share, By Therapy Class, 2020 & 2027F

4 Thailand Orphan Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Thailand Orphan Drugs Market Trends

6 Thailand Orphan Drugs Market, By Types

6.1 Thailand Orphan Drugs Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 Thailand Orphan Drugs Market Revenues & Volume, By Drugs, 2018 - 2027F

6.1.3 Thailand Orphan Drugs Market Revenues & Volume, By Revlimid, 2018 - 2027F

6.1.4 Thailand Orphan Drugs Market Revenues & Volume, By Rituxan, 2018 - 2027F

6.1.5 Thailand Orphan Drugs Market Revenues & Volume, By Opdivo, 2018 - 2027F

6.1.6 Thailand Orphan Drugs Market Revenues & Volume, By Keytruda, 2018 - 2027F

6.1.7 Thailand Orphan Drugs Market Revenues & Volume, By Imbruvica, 2018 - 2027F

6.1.8 Thailand Orphan Drugs Market Revenues & Volume, By Soliris, 2018 - 2027F

6.2 Thailand Orphan Drugs Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 Thailand Orphan Drugs Market Revenues & Volume, By Biologics, 2018 - 2027F

6.2.3 Thailand Orphan Drugs Market Revenues & Volume, By Non-Biologics, 2018 - 2027F

6.3 Thailand Orphan Drugs Market, By Therapy Class

6.3.1 Overview and Analysis

6.3.2 Thailand Orphan Drugs Market Revenues & Volume, By Oncology, 2018 - 2027F

6.3.3 Thailand Orphan Drugs Market Revenues & Volume, By Blood, 2018 - 2027F

6.3.4 Thailand Orphan Drugs Market Revenues & Volume, By Endocrine, 2018 - 2027F

6.3.5 Thailand Orphan Drugs Market Revenues & Volume, By Central Nervous Systems, 2018 - 2027F

6.3.6 Thailand Orphan Drugs Market Revenues & Volume, By Cardiovascular, 2018 - 2027F

6.3.7 Thailand Orphan Drugs Market Revenues & Volume, By Respiratory, 2018 - 2027F

7 Thailand Orphan Drugs Market Import-Export Trade Statistics

7.1 Thailand Orphan Drugs Market Export to Major Countries

7.2 Thailand Orphan Drugs Market Imports from Major Countries

8 Thailand Orphan Drugs Market Key Performance Indicators

9 Thailand Orphan Drugs Market - Opportunity Assessment

9.1 Thailand Orphan Drugs Market Opportunity Assessment, By Drugs, 2020 & 2027F

9.2 Thailand Orphan Drugs Market Opportunity Assessment, By Drug Type, 2020 & 2027F

9.3 Thailand Orphan Drugs Market Opportunity Assessment, By Therapy Class, 2020 & 2027F

10 Thailand Orphan Drugs Market - Competitive Landscape

10.1 Thailand Orphan Drugs Market Revenue Share, By Companies, 2020

10.2 Thailand Orphan Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All